Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.
about
A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum.The antiviral effect of jiadifenoic acids C against coxsackievirus B3.RNAi2013: RNAi at OxfordVirus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis.Purification of Houttuynia cordata Thunb. Essential Oil Using Macroporous Resin Followed by Microemulsion Encapsulation to Improve Its Safety and Antiviral Activity.Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies.
P2860
Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacological and biological ...... iac coxsackievirus infections.
@ast
Pharmacological and biological ...... iac coxsackievirus infections.
@en
Pharmacological and biological ...... iac coxsackievirus infections.
@nl
type
label
Pharmacological and biological ...... iac coxsackievirus infections.
@ast
Pharmacological and biological ...... iac coxsackievirus infections.
@en
Pharmacological and biological ...... iac coxsackievirus infections.
@nl
prefLabel
Pharmacological and biological ...... iac coxsackievirus infections.
@ast
Pharmacological and biological ...... iac coxsackievirus infections.
@en
Pharmacological and biological ...... iac coxsackievirus infections.
@nl
P2093
P1433
P1476
Pharmacological and biological ...... diac coxsackievirus infections
@en
P2093
Anja Geisler
Henry Fechner
Sandra Pinkert
Wolfgang Poller
P304
P356
10.3390/MOLECULES16108475
P407
P50
P577
2011-10-11T00:00:00Z